Atadas, Inc. Company Profile

Background

Overview

Atadas, Inc., now operating under the brand iPEAC® Solutions, is a telehealth technology company specializing in remote monitoring of medication-assisted treatment (MAT) for substance use disorders, particularly opioid use disorder (OUD). Founded in 2020, the company is headquartered in Salt Lake City, Utah. iPEAC stands for Integrated Program Empowerment, Accountability, and Compliance, reflecting the company's mission to enhance government efficiency and modernization through innovative software solutions.

Mission and Vision

The company's mission is to support government organizations by providing GovTech-based digital approaches and embedded AI to make constituent delivery services more accessible, efficient, and transparent. Their vision encompasses delivering integrated program empowerment, accountability, and compliance solutions across various sectors, including healthcare, defense, and law enforcement.

Industry Significance

iPEAC Solutions plays a pivotal role in the healthcare and government sectors by offering advanced software solutions that address challenges in medication management, patient engagement, and regulatory compliance. Their focus on remote monitoring and AI integration positions them as a significant player in the telehealth and GovTech industries.

Key Strategic Focus

Core Objectives

Enhancing Patient Engagement: Developing platforms that improve communication between patients and healthcare providers, leading to better treatment adherence and outcomes.

Ensuring Regulatory Compliance: Providing tools that assist healthcare providers in meeting state and federal regulations, thereby reducing administrative burdens and potential legal risks.

Expanding Market Reach: Broadening their product portfolio to serve various government sectors, including the Department of Defense, judicial and law enforcement agencies, and others.

Areas of Specialization

Medication-Assisted Treatment (MAT): Focusing on remote monitoring solutions for patients undergoing MAT for OUD.

Government Technology (GovTech): Developing compliance-driven software solutions for various government agencies.

Key Technologies Utilized

Artificial Intelligence (AI): Integrating AI to predict patient dropout rates and identify individuals at risk of relapse, enabling early intervention.

Telehealth Platforms: Offering cloud-based solutions that facilitate remote patient monitoring and communication.

Primary Markets Targeted

Healthcare Providers: Including addiction treatment centers and outpatient clinics.

Government Agencies: Such as the Department of Defense, Department of Justice, and law enforcement agencies.

Financials and Funding

Funding History

Atadas, Inc. has been primarily self-funded by founder and CEO Bill Farr, who has invested approximately $1.2 million into the company. The company has also received support from the Project Healthcare Portfolio 2021-22, an initiative by the Nashville Entrepreneur Center.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

Project Healthcare Portfolio 2021-22: An initiative by the Nashville Entrepreneur Center that supports healthcare startups.

Utilization of Capital

The capital has been utilized for product development, market expansion, and enhancing technological capabilities, particularly in AI integration and telehealth solutions.

Pipeline Development

Key Pipeline Candidates

AddMedPro® Platform: A telehealth platform designed for remote monitoring of MAT, including features like medication adherence reminders, pill counts, and recovery assessment monitoring.

Stages of Development

Product Launch: The AddMedPro® platform was launched in November 2021.

Target Conditions

Opioid Use Disorder (OUD): The primary focus is on patients undergoing MAT for OUD.

Anticipated Milestones

Expansion into New Markets: Plans to extend services to various government sectors, including defense and law enforcement.

Technological Platform and Innovation

Proprietary Technologies

PillCountPro™: A patented system that automates patient pill counts, reducing administrative time and ensuring compliance.

Significant Scientific Methods

AI-Driven Predictive Analytics: Utilizing AI to predict patient dropout rates and identify individuals at risk of relapse, enabling early intervention.

Leadership Team

William (Bill) Farr – CEO and Founder

Professional Background: A serial tech entrepreneur with 26 years of experience, having authored two technology patents and founded four companies, two of which had successful exits.

Key Contributions: Led the development and launch of the AddMedPro® platform and spearheaded the company's expansion into various government sectors.

Competitor Profile

Market Insights and Dynamics

Market Size and Growth Potential: The telehealth and GovTech sectors are experiencing significant growth, driven by increased adoption of digital health solutions and the need for efficient government services.

Industry Trends: There is a growing emphasis on AI integration, remote patient monitoring, and compliance-driven software solutions.

Competitor Analysis

Solana Networks: Offers telehealth solutions with a focus on remote patient monitoring.

Bits of Good: Provides technology solutions for healthcare providers, including patient engagement tools.

Cordell: Specializes in compliance-driven software solutions for healthcare and government sectors.

Strategic Collaborations and Partnerships

Spero Health: Partnered to expand the AddMedPro® platform across multiple states, enhancing patient retention in outpatient addiction treatment programs.

Navajo Nation Department of Health: Awarded a multi-year contract to support opioid use disorder surveillance and medication-assisted treatment.

Operational Insights

Strategic Considerations

Major Competitors: Companies like Solana Networks, Bits of Good, and Cordell offer similar solutions in the telehealth and GovTech spaces.

Market Position: iPEAC Solutions differentiates itself through its patented technologies, AI integration, and focus on both healthcare and government sectors.

Competitive Advantages: Proprietary technologies like PillCountPro™, AI-driven predictive analytics, and a comprehensive suite of compliance-driven solutions.

Strategic Opportunities and Future Directions

Strategic Roadmap

Product Expansion: Developing new features and services to address a broader range of government and healthcare needs.

Market Penetration: Increasing presence in additional states and government sectors, leveraging existing partnerships and contracts.

Technological Advancements: Continuing to integrate advanced technologies like AI and machine learning to enhance product offerings.

Future Business Directions

Diversification: Expanding product offerings to include solutions for other substance use disorders and healthcare challenges.

Global Expansion: Exploring opportunities to offer solutions in international markets facing similar healthcare and government efficiency challenges.

Opportunities for Expansion

Government Contracts: Pursuing additional contracts with federal, state, and local government agencies to provide compliance-driven software solutions.